A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Auckland Hospital, Grafton

Hospital General de Agudos 'Teodoro Alvarez', Buenos Aires

Hospital Interzonal General de Agudos, Oscar Alende, Buenos Aires

CAICI, Buenos Aires

Albion Street Centre, Sydney

St Vincent's Hospital, Sydney

Liverpool Hospital, Liverpool

The Alfred Hospital, Melbourne

Centre Clinic, Melbourne

Hospital Central, Mendoza

Tan Tock Seng Hospital, Singapore

FUNCEI, Buenos Aires

Hospital de Infecciosas FJ Muniz, Buenos Aires

Hospital Italiano, Buenos Aires

Hospital J.M. Ramos Mejia, Buenos Aires

Hospital Prof. Alejandro Posadas, Buenos Aires

Hospital Rawson, Córdoba

Hospital de la Universidad Catolica Pontificia, Santiago

Hospital San Borja-Arriaran, Santiago

Hopital Saint-Louis, Paris

Medical Group Practice, Berlin

J W Goethe Universitat, Frankfurt

Queen Elizabeth Hospital, Hong Kong

YRG Care, Chennai

Institute of Infectious Diseases, Pune

Mater Misericordiae-Dublin, Dublin

Hospital Pelau Pinang, Kuala Lumpur

Hospital Sungai Buloh, Kuala Lumpur

University of Malaysia, Kuala Lumpur

Hospital General de Guadalajara, Guadalajara

Hospital General de Leon, León

"Instituto Nacional de Ciencias Medicas y Nutricion Salvado Zubiran", Mexico City

Evangel Hospital (ECWA), Jos

Jos University Teaching Hospital (JUTH), Jos

Plateau State Specialist Hospital, Jos

Hospital Almenara, Lima

IMPACTA/Hospital Dos de Mayo, Lima

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima

Via Libre, Lima

Josha Research, Bloemfontein

Desmond Tutu HIV Foundation, Cape Town

Chris Hani Baragwanath Hospital, Soweto

National Taiwan University Hospital, Taipei

Chelsea and Westminster Hospital, Fulham